New hope for Tough-to-Treat lung cancer: testing a powerful drug cocktail
NCT ID NCT05074810
Summary
This study is testing a new combination of two or three drugs for people with a specific type of lung cancer (KRAS G12C Non-Small Cell Lung Cancer). It aims to see if the combination is safe and effective, especially for patients whose cancer has progressed after previous treatments, including similar targeted drugs. The trial includes people who have and have not tried a KRAS G12C inhibitor before.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alliance Cancer Specialists,
Horsham, Pennsylvania, 19044, United States
-
CHRU of Lille
Lille, 59037, France
-
CHU de Liège
Liège, 4000, Belgium
-
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, 44195, United States
-
Consultants in Medical Oncology & Hematology
Broomall, Pennsylvania, 19008, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Erasmus MC
Rotterdam, 3015 GD, Netherlands
-
Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
Hospital General Universitario Gregorio Marañón
Madrid, 28007, Spain
-
Hospital Teresa Herrera (C.H.U.A.C)
A Coruña, 15006, Spain
-
Hospital Universitario Fundación Jiménez Díaz
Madrid, 28040, Spain
-
Hospital Universitario Virgen De La Victoria
Málaga, 29010, Spain
-
Hospital Universitario Virgen de la Macarena
Seville, 41009, Spain
-
Hôpital Cochin
Paris, 75014, France
-
Hôpital Foch
Suresnes, 92150, France
-
Illinois Cancer Specialists
Arlington Heights, Illinois, 60005, United States
-
Leids Universitair Medisch Centrum
Leiden, 2333 ZA, Netherlands
-
Maryland Oncology & Hematology, P.A.
Rockville, Maryland, 20850, United States
-
MedStar Washington Hospital Center, MedStar Georgetown Cancer Institute,
Washington D.C., District of Columbia, 20010, United States
-
Minnesota Oncology Hematology, P.A
Woodbury, Minnesota, 55125, United States
-
Northwest Cancer Specialists
Vancouver, Washington, 98684, United States
-
Ohio State University Brain and Spine Hospital
Columbus, Ohio, 43210, United States
-
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
Blacksburg, Virginia, 24060, United States
-
Rocky Mountain Cancer Center, LLP
Boulder, Colorado, 80303, United States
-
Royal Marsden Hospital
London, SW3 6JJ, United Kingdom
-
Royal Marsden Hospital
Sutton, SM2 5PT, United Kingdom
-
Texas Oncology
Austin, Texas, 78731, United States
-
Texas Oncology
Longview, Texas, 75601, United States
-
Texas Oncology - Fort Worth Cancer Center
Fort Worth, Texas, 76104, United States
-
University Hospital Gent
Ghent, 9000, Belgium
-
University of Leicester
Leicester, LE2 7LX, United Kingdom
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
-
Virginia Cancer Specialists, PC
Fairfax, Virginia, 22031, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.